机译:用于重新编程免疫抑制肿瘤微环境和增强癌症免疫疗法的纳米工程免疫力
Sungkyunkwan Univ SKKU Adv Inst Nanotechnol SAINT Dept Nano Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea|Sungkyunkwan Univ Sch Chem Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea;
Sungkyunkwan Univ SKKU Adv Inst Nanotechnol SAINT Dept Nano Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea|Sungkyunkwan Univ Sch Chem Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea;
Sungkyunkwan Univ SKKU Adv Inst Nanotechnol SAINT Dept Nano Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea|Sungkyunkwan Univ Sch Chem Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea;
Sungkyunkwan Univ SKKU Adv Inst Nanotechnol SAINT Dept Nano Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea|Sungkyunkwan Univ Sch Chem Engn 2066 Seobu Ro Suwon 16419 Gyeonggi Do South Korea;
antitumor immunity; cancer immunotherapy; immunosuppression; nanoengineered immune niches; tumor microenvironment;
机译:纳米工程免疫壁ches,用于重编程免疫抑制性肿瘤微环境和增强癌症免疫疗法
机译:通过二次近三红外窗口的PD-L1介导的PD-L1进行重新编程肿瘤微环境,用于增强癌症免疫疗法
机译:冻干和多方型的Toll样受体7/8激动剂负载纳米乳液,用于重编程肿瘤微环境和增强的癌症免疫疗法
机译:炎症和癌症:重新编程免疫微环境作为抗癌治疗策略
机译:肿瘤免疫学:了解免疫系统和癌症,以提高癌症免疫治疗的疗效
机译:用pH响应杂交膜涂层纳米粒子调节免疫抑制肿瘤微环境以增强乳腺癌免疫疗法
机译:通过重新编程肿瘤微环境,基质金属蛋白酶抑制剂在乳腺癌中增强抗细胞毒性T淋巴细胞抗原-4抗体免疫疗法
机译:通过阻断前列腺肿瘤来源的免疫抑制因子增强肿瘤免疫治疗